Keywords: سرطان مثانه غیر تهاجمی تهاجمی; AT-Rich interaction domain 1A; Bacillus Calmette-Guérin; DNA damage repair; Genomics; Immunotherapy; Nonmuscle invasive bladder cancer; Targeted therapy;
مقالات ISI سرطان مثانه غیر تهاجمی تهاجمی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; cystoscopy; aminolevulinic acid; photochemotherapy; drug-related side effects and adverse reactions; AE; adverse event; BLC; blue light cystoscopy; CIS; carcinoma in situ; CTCAE; Common Terminology Criteria for Adverse Events; F
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; BCG vaccine; cancer vaccines; cell cycle checkpoints; immunotherapy; urologic neoplasms; AE; adverse event; APC; antigen presenting cell; BCG; bacillus Calmette-Guérin; CAR; chimeric antigen receptor; CIS; carcinoma in situ; CTA; cancer testis antigen; C
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; administration; intravesical; BCG vaccine; mitomycin; interferons; BCG; bacillus Calmette-Guérin; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; SOE; strength of evidence; TURBT; transurethral bladder tumor resecti
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; fluorescence; cystoscopy; aminolevulinic acid; urinary bladder neoplasms; 5-ALA; 5-aminolevulinic acid; HAL; hexaminolevulinic acid; NMIBC; nonmuscle invasive bladder cancer; RCT; randomized, controlled trial; SOE; strength of evidence; TURBT; transurethr
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; bladder neoplasms; risk assessment; practice guidelines as topic; mortality; BCG vaccine; BCG; bacillus Calmette-Guérin; CUETO; Club Urológico Español de Tratamiento Oncológico; EORTC; European Organization for Research and Treatment of Cancer; NCCN®
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; drug therapy; neoplasm recurrence; local; guideline adherence; practice patterns; physicians'; IPIOC; immediate postoperative instillation of chemotherapy; NMIBC; nonmuscle invasive bladder cancer; TUR; transurethral resection
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; Fluorescence-based photodynamic diagnostic; Nonmuscle invasive bladder cancer; Blue light cystoscopy
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; Nonmuscle invasive bladder cancer; Diagnostic biomarkers; Prognostic biomarkers; DNA; RNA; Protein; Urine;
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; Nonmuscle invasive bladder cancer; High-risk bladder cancer; High-grade T1; HGT1; Carcinoma in situ; CIS; TUR; reTUR;
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; incidence; urinary bladder neoplasms; neoplasm staging; Spain; BC; bladder cancer; BCG; bacillus Calmette-Guérin; BMI; body mass index; CIS; carcinoma in situ; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral bladder tumor
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; mycobacterium bovis; administration; intravesical; chemotherapy; adjuvant; risk; AUA; American Urological Association; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CUETO; Club Urologico Espanol de Tratamiento Oncologi
The Role of Vitamin D Receptor Polymorphisms in Predicting the Response to Therapy for Nonmuscle Invasive Bladder Carcinoma
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; carcinoma; polymorphism; single nucleotide; receptors; calcitriol; BCG vaccine; 1,25-VD; activated vitamin D; BCG; bacillus Calmette-Guérin; NMIBC; nonmuscle invasive bladder cancer; PCR; polymerase chain reaction; SNP; single
Outpatient Holmium laser fulguration: A safe procedure for treatment of recurrence of nonmuscle invasive bladder cancer
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; Nonmuscle invasive bladder cancer; Outpatient fulguration; Holmium laser; Cáncer vesical no músculo-invasivo; Fulguración ambulatoria; Láser Holmium;
Predicting the tumorigenic phenotype of human bladder cancer cells by combining with fetal rat mesenchyme
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; Invasive bladder cancer; Responsiveness of cancer cells to stroma; Fetal mesenchyme; Micropapillary-like structures; p63 isoforms; BLM; bladder mesenchyme; CIS; carcinoma in situ; EMT; epithelial-mesenchymal transition; H&E; hematoxylin and eosin; MIBC; m
Exploring Patterns of Mitomycin C Use in Community Practice Urology
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; endoscopy; mitomycin; community health services; quality improvement; CCI; Charlson comorbidity index; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral bladder tumor resection;
Purified Protein Derivative Skin test prior to bacillus Calmette-Guérin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; BCG vaccine; adjuvants; immunologic; skin tests; adverse effects; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; LUTS; lower urinary tract symptoms; NMIBC; nonmuscle invasive bladder cancer; PFS; progression-free surviv
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; neoplasm recurrence; local; urinalysis; cystoscopy; neoplasm invasiveness; CIS; carcinoma in situ; EAU; European Association of Urology; HG; high grade; LG; low grade; MIBC; muscle invasive bladder cancer; NMIBC; nonmuscle inva
Efficacy of bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; BCG vaccine; immunotherapy; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; FDA; United States Food and Drug Administration; MeSH; Medical Subject Headings; NMIBC; nonmuscle invasive bladder cancer; PRISMA; Preferred Rep
Therapeutic Use of Mitomycin C for Urological Conditions: Systematic Review of the Literature
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urethra; urinary bladder neoplasms; mitomycin; anticarcinogenic agents; urological agents; BCG; bacillus Calmette-Guérin; BNC; bladder neck contracture; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer;
The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; BCG vaccine; treatment failure; cystectomy; mortality; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CSS; cancer specific survival; HG; high grade; IFN; interferon; IVT; intravesical therapy; LVI; lymphovascular invasi
Transurethral Bladder Tumor Resection Can Cause Seeding of Cancer Cells into the Bloodstream
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; neoplastic cells; circulating; neoplasm metastasis; CTC; circulating tumor cell; CV; central vein; IVC; inferior vena cava; MIBC; muscle invasive bladder cancer; NMIBC; nonmuscle invasive bladder cancer; PV; peripheral vein; TUR
Process Improvements Positively Impact the Use of Intravesical Mitomycin C after Transurethral Resection of Nonmuscle Invasive Bladder Cancer in a Large, Urban Urology Practice
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; mitomycin; urinary bladder neoplasms; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; TURB; transurethral resection of the bladder;
TaG1 Bladder Cancer: A Third of All Primary Tumors and 80% of All Recurrences Can Be Treated in the Office Using Local Anesthesia
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; neoplasm recurrence; local; cystoscopy; anesthesia; physicians' offices; GA; general anesthesia; LA; local anesthesia; NMIBC; nonmuscle invasive bladder cancer; OR; operating room; TUR; transurethral resection;
Epigenetic Inactivation of KLF4 is Associated with Urothelial Cancer Progression and Early Recurrence
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder; urothelium; carcinoma; genes; tumor suppressor; mortality; 5-AZA-dc; 5-aza-2-deoxycytidine; EMT; epithelial-to-mesenchymal transition; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; KLF4; Krüppel-like factor 4; NMIBC; nonmuscle invasiv
Upper Tract Imaging Surveillance is not Effective in Diagnosing Upper Tract Recurrence in Patients Followed for Nonmuscle Invasive Bladder Cancer
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; carcinoma; transitional cell; urinary bladder neoplasms; diagnostic imaging; watchful waiting; CIS; carcinoma in situ; CT; computerized tomography; IVP; excretory urography; MSKCC; Memorial Sloan-Kettering Cancer Center; NMIBC; nonmuscle invasive bladder
Disease Specific Mortality in Patients with Low Risk Bladder Cancer and the Impact of Cystoscopic Surveillance
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder; urinary bladder neoplasms; risk; cystoscopy; Great Britain; BC; bladder cancer; DSM; disease specific mortality; MIBC; muscle invasive BC; NHS; National Health Service; NMI; nonmuscle invasive; NMIBC; nonmuscle invasive bladder cancer; UC
Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; apaziquone; urinary bladder neoplasms; drug therapy; administration; intravesical; AE; adverse event; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral resection of bla
National Practice Patterns for Immediate Postoperative Instillation of Chemotherapy in Nonmuscle Invasive Bladder Cancer
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; drug therapy; administration, intravesical; physician's practice patterns; urology; AUA; American Urological Association; CIS; carcinoma in situ; IPOC; intravesical postoperative chemotherapy; IPOIC; immediate postoperative inst
Understanding the Use of Immediate Intravesical Chemotherapy for Patients with Bladder Cancer
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; administration; intravesical; drug therapy; quality improvement; IRB; institutional review board; IVC; intravesical chemotherapy; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral resection of bladder tumor; USQC; U
Economic and Humanistic Consequences of Preventable Bladder Tumor Recurrences in Nonmuscle Invasive Bladder Cancer Cases
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; administration, intravesical; mitomycin; economics, pharmaceutical; quality-adjusted life years; BCG; bacillus Calmette-Guérin; IVIC; intravesical instillation of chemotherapy; MMC; mitomycin C; NMIBC; nonmuscle invasive bladde
Impact of Smoking on Outcomes of Patients with a History of Recurrent Nonmuscle Invasive Bladder Cancer
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder; urothelium; carcinoma; smoking; survival; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CPD; cigarettes per day; NMIBC; nonmuscle invasive bladder cancer; TURB; transurethral resection of bladder; UCB; urothelial carcinoma of bl
Usefulness of the Spanish Urological Club for Oncological Treatment Scoring Model to Predict Nonmuscle Invasive Bladder Cancer Recurrence in Patients Treated With Intravesical Bacillus Calmette-Guérin Plus Interferon-α
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder; urinary bladder neoplasms; BCG vaccine; interferon alfa-2b; prognosis; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CUETO; Spanish Urological Club for Oncological Treatment; EORTC; European Organization for Research and Treatme
Frequency of Tumor Recurrence: A Strong Predictor of Stage Progression in Initially Diagnosed Nonmuscle Invasive Bladder Cancer
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; disease progression; recurrence; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; FTR; frequency of tumor recurrence; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral resection of bladder tumor;
Nonprimary pT1 Nonmuscle Invasive Bladder Cancer Treated With Bacillus Calmette-Guerin is Associated With Higher Risk of Progression Compared to Primary T1 Tumors
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; disease progression; recurrence; mortality; BCG vaccine; BCG; bacillus Calmette-Guerin; CIS; carcinoma in situ; DSS; disease specific survival; NMI-BC; nonmuscle invasive bladder cancer; PFS; progression-free survival; RFS; recu
Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study
Keywords: سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; mycobacterium bovis; administration; intravesical; chemotherapy; adjuvant; epirubicin; BCG; bacillus Calmette-Guerin; CIS; carcinoma in situ; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral resection of bladder tu